Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Sirona Biochem Corp
Bullboard Posts
User Avatar Image
(4)
•••
Comment by bazooka73on Jan 23, 2017 4:12am
147 Views
Post# 25740046

RE:RE:RE:Around the corner - New Insider

RE:RE:RE:Around the corner - New Insider
malibuki wrote:
I should admit this pumping route is smarter than previous funny videos. Big guesses without signature of the management without responsibility of the content. After waiting 2 years, I do not mind 2 weeks more. You have a single shot missmarie, if you miss you would be part of the nonsense list as presentation guidelines, videos.... BTW if you are so sure why do not you share pic of your account showing number of shares you have? You claim to have 4X valued information then you should probably be all in.



If you take a look at the posts of Misstake... sorry Missunderstanding... outch.. I mean Missmarie ;-) you will easily learn that due to the chosen record layout combined with the grammatical errors and the general bad english, it does come from the same person who is also posting (or used to post) under the aliases like diamondlessnono, DrBalnora etc. etc.
Or as I call it: Same sh.t, different name!

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities